New method makes epigenetic aging clocks accurate and easier to interpret

Researchers at the Leibniz Institute on Aging, Fritz Lipmann Institute (FLI) in Germany, in collaboration with scientists from the Hebrew University of Jerusalem, the University of Edinburgh, and Queen Mary University of London, have developed a novel epigenetic clock called the TFMethyl Clock. This tool improves both the accuracy of age prediction and the ability to interpret the biological mechanisms behind aging. Published in the journal Nucleic Acids Research, the study introduces a method that integrates precise aging forecasts with enhanced understanding of molecular aging processes. Epigenetic clocks measure biological age by analyzing DNA methylation patterns, chemical modifications to DNA that affect gene activity. While existing clocks are highly effective at predicting age, they often lack clarity on the specific biological pathways driving aging. The TFMethyl Clock addresses this limitation by focusing on DNA methylation sites that regulate gene expression through transcription factor binding. Transcription factors act as switches, turning genes on or off, and play a key role in cellular functions related to aging. The research team conducted a comprehensive analysis of DNA methylation sites used in current epigenetic clocks. They found that many of these sites were not located within experimentally confirmed transcription factor binding regions. This suggested that existing models might not fully capture the genetic regulatory networks involved in aging. To improve accuracy and interpretability, the researchers focused on methylation sites that directly influence gene expression during aging. By examining these sites, the team discovered a subset of regulatory methylation positions linked to aging-related processes. These included signaling pathways associated with interleukin-1β production and fatty acid metabolism. Interleukin-1β is a cytokine involved in inflammation, while fatty acid metabolism plays a critical role in energy balance and cellular health. These findings suggest that certain molecular pathways may directly impact the rate of biological aging. The TFMethyl Clock model, built using this refined set of methylation sites, demonstrates exceptional precision in age prediction. Unlike traditional clocks, it provides insight into the biological mechanisms that may drive aging. According to the study’s lead author, Tushar Patel, the model represents a significant advancement in the field. Co-author Steve Hoffmann noted that constructing the clock from regulatory DNA methylation sites enhances its biological relevance. Alena van Bömmel, another co-author and soon-to-be professor at Ludwig-Maximilians University of Munich, emphasized that the model not only achieves high accuracy but also reveals potential targets for further research. The TFMethyl Clock could aid in studying age-related diseases and evaluating interventions aimed at slowing aging. Its integration of predictive power with mechanistic understanding sets a new standard for epigenetic clocks. This breakthrough underscores the growing importance of epigenetic research in aging science. As the global population ages, tools that accurately assess biological age and identify contributing factors will become increasingly valuable. The TFMethyl Clock represents a step forward in making aging research more transparent and actionable. Future studies may build upon this work to explore how lifestyle, environment, and disease interact with these molecular pathways.